These include studies of molecular structure, genetics, biochemistry, immunology, cell and animal models, and clinical research - including therapeutic development.
Researchers from the Institute of Prion Diseases have developed experimental treatments for prion diseases including a humanised antibody and, in collaboration with the pharmaceutical industry, new small molecule therapeutics.
Mechanisms of protein misfolding and neurotoxicity that may be relevant to more common neurodegenerative diseases like Alzheimer’s disease are also being investigated.
| 
| 
|
| 
|
|
|
|
|
|
| |